For help on how to get the results you want, see our search tips.
5 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Conditional approval Remove Conditional approval filter
Exceptional circumstances Remove Exceptional circumstances filter
Orphan medicine Remove Orphan medicine filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Nexviadyme
Avalglucosidase alfa, opinion date: 23/07/2021, Positive, Last updated: 02/08/2021 -
List item
Summary of opinion: Flynpovi
eflornithine, sulindac, opinion date: 24/06/2021, Negative, Last updated: 23/07/2021 -
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Lonapegsomatropin Ascendis Pharma
lonapegsomatropin, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Oxbryta
Voxelotor, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021